Home > Community > Chemicals > CSL sees A$300 mln swine flu vaccine sales in 2010

CSL sees A$300 mln swine flu vaccine sales in 2010

Published: 18 Aug 2009 21:29:12 PST

MELBOURNE, Aug 19 - Australian biotherapies group CSL Ltd expects to book sales of around A$300 million ($248 million) from swine flu vaccines in the year to June 2010, Chief Executive Brian McNamee said on Wednesday.

The company has a $180 million order to supply the U.S. government plus an order from the Australian government.

"I think heading towards A$300 (million) is a reasonable estimate," he told reporters. ($1=1.21 Australian Dollar)


Source: Reuters

If you believe an article violates your rights or the rights of others, please contact us.

Share this story:
  • Digg
  • Reddit
  • Mixx it
  • Facebook
Email this page Bookmark this page